(Q44123100)

30 November 2017

title

Effects of 8:00 A.M. and 2:00 P.M. Doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

18 October 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

18 October 2022

author name string

U. Thadani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1632390

18 October 2022

N. Bittar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1632390

18 October 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:000291499290606Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

https://api.elsevier.com/content/article/PII:000291499290606Y?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

American Journal of Cardiology

18 October 2022

published in

1 reference

30 November 2017

volume

70

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

286-292

1 reference

Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate

30 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

18 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Transdermal nitroglycerin in angina pectoris

18 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance

18 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study

18 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

A reappraisal of nitrate therapy

18 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance

18 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

18 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Antianginal effects of intravenous nitroglycerin over 24 hours

18 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Effect of intervals between doses on the development of tolerance to isosorbide dinitrate

18 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

18 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Induction and circumvention of nitrate tolerance applying different dosage intervals

18 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Interval therapy to avoid nitrate tolerance: paradise regained?

18 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Limited usefulness of intermittent nitroglycerin patches in stable angina

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate

18 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Analysis, disposition and pharmacokinetics of nitroglycerin

18 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations

18 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Clinical pharmacokinetics of organic nitrates

18 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates

18 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Isosorbide 5‐mononitrate pharmacokinetics in humans

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy

18 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Dose dependence of tolerance during treatment with mononitrates

18 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris

18 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)90606-Y

18 October 2022

Identifiers

1 reference

30 November 2017

1 reference